Laboratory

The measured serum or plasma creatinine value recorded as part of a hematology or comprehensive metabolic workup, used to assess kidney function in patients undergoing treatment for blood disorders. Elevated creatinine may influence dosing decisions for nephrotoxic hematologic therapies.

The calendar date associated with a hematology event, such as the date a blood test was ordered, collected, or resulted. Used in clinical workflows, laboratory information systems, and population health reporting to establish the timeline of blood study activity for a patient.

The combined date and time value marking a specific hematology event, such as specimen collection or result release, recorded in the laboratory or clinical information system. Enables precise sequencing of blood study activities and supports time-sensitive clinical decision-making.

The Drug Enforcement Administration registration number associated with a prescribing clinician who orders controlled substances as part of hematology treatment protocols, such as opioids for pain management in sickle cell disease. Used for regulatory compliance and controlled substance tracking.

The recorded date of death for a patient associated with a hematology record, used in longitudinal blood disorder tracking, clinical trial data, and mortality reporting for conditions such as leukemia or aplastic anemia. Supports outcomes analysis and registry reporting for hematologic diseases.

The dollar amount applied toward a member's annual deductible for hematology services, such as diagnostic blood panels or hematologic specialist visits, before the health plan begins covering costs. Captured on claims and remittance data to track member cost-sharing accumulation across the benefit year.

The calendar date on which a hematology record was marked as deleted or voided in the clinical or laboratory information system. Used in data governance, audit trails, and soft-delete workflows to preserve a record of when a blood study entry was removed without permanent data loss.

A flag indicating that a hematology record has been logically removed or voided from active use in the clinical or laboratory information system without being permanently purged. Used to exclude invalid or duplicate blood study records from reporting while preserving data history for audit purposes.

A human-readable text field providing the name or explanatory narrative of a hematology test, procedure, or blood disorder diagnosis. Used in clinical documentation, laboratory orders, and reporting interfaces to clearly identify the nature of a blood study for clinicians and administrative staff.

Granular clinical or administrative information associated with a specific hematology record, such as methodology, specimen type, reference ranges, or result interpretation notes for a blood study. Stored in laboratory information systems to support detailed clinical review and downstream analytical reporting.

The deadline by which a hematology lab order, result review, or follow-up action must be completed. Used in laboratory information systems to manage turnaround time compliance and ensure timely clinical review of blood study findings such as CBC or coagulation panels.

The total elapsed time for a hematology-related process, such as the length of a treatment course, the time a specimen was in processing, or the span of a monitored blood disorder episode. Used in clinical data systems to track hematology workflow and treatment timelines.

The date on which a hematology order, result, diagnosis, or treatment protocol becomes clinically active. Used in laboratory and clinical systems to establish when blood study findings or hematologic treatment plans are valid for use in patient care decisions.

The electronic mail address associated with the patient, ordering clinician, or hematology department contact linked to a blood study. Used in clinical communication workflows to deliver lab result notifications, critical value alerts, or hematology consultation correspondence.

A flag designating whether a hematology lab order or blood study requires urgent or STAT processing due to a critical clinical condition such as severe anemia, leukemia suspicion, or acute coagulopathy. Drives prioritization in laboratory information systems and result routing workflows.

The date on which a hematology order, monitoring period, or treatment protocol is completed or discontinued. Used in clinical data systems to define the closing boundary of a blood study episode and support longitudinal tracking of hematologic conditions and therapies.

The precise time at which a hematology procedure, specimen collection, processing run, or monitoring interval concludes. Used in laboratory information systems to calculate turnaround times, ensure chain-of-custody accuracy, and support audit trails for blood study workflows.

The identifier of the clinical staff member or system user who recorded or submitted the hematology order, result, or related data entry. Used in laboratory and EHR audit logs to maintain accountability and traceability for blood study documentation and result entry.

The self-reported or recorded ethnic background of the patient associated with a hematology record. Used in clinical data systems to support population health analysis, identify ethnic-specific hematologic conditions such as sickle cell disease or thalassemia, and ensure equitable care reporting.

The date after which a hematology order, authorization, specimen, or reagent is no longer considered valid for clinical use. Used in laboratory systems to prevent processing of outdated specimens, expired reagents, or lapsed hematology orders, ensuring result accuracy and patient safety.